Please Wait.....
Report
Global Exosome Drug Market Report and Forecast 2023-2031
Market Report I 2023-04-16 I 147 Pages I EMR Inc.
Global Exosome Drug Market Report and Forecast 2023-2031
Global Exosome Drug Market Outlook
The global exosome drug market size attained a value of USD 21.949 million in 2022. The market is likely to grow at a CAGR of 6.55% during the forecast period of 2023-2031 to attain a value of USD 38.85 million by 2031.
Exosome Drug Market: Introduction
Exosomes are small extracellular vesicles secreted by various cells and are involved in intercellular communication. They play a critical role in the maintenance of cellular homeostasis and are being increasingly recognized as potential drug delivery vehicles for the treatment of various diseases. The report by Expert Market Research covers the market for exosomes drugs and provides a detailed analysis of the market size, growth, and trends. The global exosomes drug market is highly competitive, with several key players operating in the space. The key players in the market are expected to focus on research and development activities to develop innovative products and gain a competitive edge.
Exosome Drug - Application and Uses
Exosomes have been identified as potential therapeutic agents for a range of diseases, including cancer, neurological disorders, cardiovascular diseases, and inflammatory disorders. The prevalence of these diseases is increasing globally, which is expected to drive the demand for exosome-based therapies.
Cancer is one of the leading causes of death worldwide, with approximately 10 million deaths per year. The rising prevalence of cancer is expected to drive the growth of the exosome drug market. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and was responsible for an estimated 9.6 million deaths in 2018. The WHO also estimates that the number of new cancer cases will rise by about 70% over the next two decades.
Neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, are also on the rise globally, driven by aging populations and changing lifestyles. According to the World Alzheimer Report, there were an estimated 50 million people living with dementia in 2018, and this number is expected to triple by 2050. The rising prevalence of neurodegenerative disorders is expected to drive the demand for exosome-based therapies.
Cardiovascular diseases, such as heart disease and stroke, are a leading cause of death globally, accounting for an estimated 17.9 million deaths in 2019. The rising prevalence of cardiovascular diseases is expected to drive the growth of the exosome drug market.
Inflammatory disorders, such as rheumatoid arthritis and inflammatory bowel disease, are also on the rise globally, driven by changing lifestyles and environmental factors. According to the Centers for Disease Control and Prevention (CDC), an estimated 54.4 million adults in the United States have been diagnosed with arthritis, and this number is expected to rise to 78.4 million by 2040. The rising prevalence of inflammatory disorders is expected to drive the demand for exosome-based therapies.
Exosome Drug Market Segmentations
The market can be categorized into biomolecule type, product type, application, disease type, and region.
Market Breakup by Biomolecule Type
- Non-Coding RNAs
- mRNA (exoRNA)
- Proteins/ Peptides
- DNA Fragments
- Lipids
Market Breakup by Product Type
- Kits
- Reagents
- Instruments
Market Breakup by Application
- Biomarkers
- Drug Delivery System
- Vaccine Development
- Therapeutic Agents
- Others
Market Breakup by Disease Type
- Cancer Disease
- Cardiovascular Disease
- Neurodegenerative Disease
- Tissue Regeneration
- Infectious Disease
- Others
Exosome Drug Market Breakup by Region
- North America
? United States of America
? Canada
- Europe
? United Kingdom
? Germany
? France
? Italy
? Others
- Asia Pacific
? China
? Japan
? India
? ASEAN
? Australia
? Others
- Latin America
? Brazil
? Argentina
? Mexico
? Others
- Middle East and Africa
? Saudi Arabia
? United Arab Emirates
? Nigeria
? South Africa
? Others
Exosome Drug Market Scenario
North America dominates the exosomes drug market, followed by Europe and the Asia Pacific. The high prevalence of cancer and neurodegenerative diseases in North America, coupled with the availability of advanced healthcare infrastructure and increasing investment in research and development activities, is driving the growth of the market in the region. Europe is also a significant market for exosome drugs, with the presence of key players and increasing investment in research and development activities. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period, owing to the increasing prevalence of chronic diseases and rising healthcare expenditure.
However, the market growth may be hindered by factors such as the high cost of exosome-based therapies, regulatory challenges, and the lack of standardized isolation and purification methods. In addition, the limited understanding of exosome biology and the complexity of exosome-based therapies may also impede the market growth.
Key Players in the Global Exosome Drug Market
The report gives an in-depth analysis of the key players involved in the Exosome Drug market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- Danaher Corporation (Beckman Coulter Inc.)
- Hologic Inc.
- Lonza Group AG
- Fujifilm Holdings Corporation
- Miltenyi Biotec GmbH
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
- JSR Corporation (MBL International)
- Illumina, Inc.
- Takara Bio Inc.
- Malvern Instruments Ltd. (Spectris Plc Company)
- Abcam Plc.
- Ampersand Capital Partner (New England Peptide, Inc.)
- Evox Therapeutics Ltd.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
2 Research Methodology
3 Executive Summary
4 Exosomes Drug Overview
4.1 Drug Overview
4.1.1 Pharmacodynamics
4.1.2 Pharmacokinetics
4.1.3 Adverse Events
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
6 Global Exosomes Drug Market
6.1 Global Exosomes Drug Market Overview
6.2 Global Exosomes Drug Market Analysis
6.2.1 Market Overview
6.2.1.1 Global Exosomes Drug Market Historical Value (2016-2022)
6.2.1.2 Global Exosomes Drug Market Forecast Value (2023-2031)
6.3 Global Exosomes Drug Market by Biomolecule Type
6.3.1 Market Overview
6.3.1.1 Non-Coding RNAs
6.3.1.2 mRNA (exoRNA)
6.3.1.3 Proteins/Peptides
6.3.1.4 DNA Fragments
6.3.1.5 Lipids
6.4 Global Exosomes Drug Market by Product Type
6.4.1 Market Overview
6.4.1.1 Kits
6.4.1.2 Reagents
6.4.1.3 Instruments
6.5 Global Exosomes Drug Market by Application
6.5.1 Market Overview
6.5.1.1 Biomarkers
6.5.1.2 Drug Delivery System
6.5.1.3 Vaccine Development
6.5.1.4 Therapeutic Agents
6.5.1.5 Others
6.6 Global Exosomes Drug Market by Disease Type
6.6.1 Market Overview
6.6.1.1 Cancer Disease
6.6.1.2 Neurodegenerative Diseases
6.6.1.3 Cardiovascular Diseases
6.6.1.4 Infectious Diseases
6.6.1.5 Tissue Regeneration
6.6.1.6 Others
6.7 Global Exosomes Drug Market by Region
6.7.1 Market Overview
6.7.1.1 North America
6.7.1.2 Europe
6.7.1.3 Asia Pacific
6.7.1.4 Latin America
6.7.1.5 Middle East and Africa
7 North America Exosomes Drug Treatment Market
7.1 Market Share by Country
7.2 United States of America
7.2.1 Historical Trend (2016-2022)
7.2.2 Forecast Trend (2023-2031)
7.3 Canada
7.3.1 Historical Trend (2016-2022)
7.3.2 Forecast Trend (2023-2031)
8 Europe Exosomes Drug Treatment Market
8.1 Market Share by Country
8.2 United Kingdom
8.2.1 Historical Trend (2016-2022)
8.2.2 Forecast Trend (2023-2031)
8.3 Germany
8.3.1 Historical Trend (2016-2022)
8.3.2 Forecast Trend (2023-2031)
8.4 France
8.4.1 Historical Trend (2016-2022)
8.4.2 Forecast Trend (2023-2031)
8.5 Italy
8.5.1 Historical Trend (2016-2022)
8.5.2 Forecast Trend (2023-2031)
8.6 Others
9 Asia Pacific Exosomes Drug Treatment Market
9.1 Market Share by Country
9.2 China
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3 Japan
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
9.4 India
9.4.1 Historical Trend (2016-2022)
9.4.2 Forecast Trend (2023-2031)
9.5 ASEAN
9.5.1 Historical Trend (2016-2022)
9.5.2 Forecast Trend (2023-2031)
9.6 Australia
9.6.1 Historical Trend (2016-2022)
9.6.2 Forecast Trend (2023-2031)
9.7 Others
10 Latin America Exosomes Drug Treatment Market
10.1 Market Share by Country
10.2 Brazil
10.2.1 Historical Trend (2016-2022)
10.2.2 Forecast Trend (2023-2031)
10.3 Argentina
10.3.1 Historical Trend (2016-2022)
10.3.2 Forecast Trend (2023-2031)
10.4 Mexico
10.4.1 Historical Trend (2016-2022)
10.4.2 Forecast Trend (2023-2031)
10.5 Others
11 Middle East and Africa Exosomes Drug Treatment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.2.1 Historical Trend (2016-2022)
11.2.2 Forecast Trend (2023-2031)
11.3 United Arab Emirates
11.3.1 Historical Trend (2016-2022)
11.3.2 Forecast Trend (2023-2031)
11.4 Nigeria
11.4.1 Historical Trend (2016-2022)
11.4.2 Forecast Trend (2023-2031)
11.5 South Africa
11.5.1 Historical Trend (2016-2022)
11.5.2 Forecast Trend (2023-2031)
11.6 Others
12 Current Scenario Evaluation and Regulatory Framework
12.1 Emerging Therapies and Clinical Trials Synopsis
12.2 Patent Landscape
12.2.1 Patent Overview
12.2.1.1 Patent Status and Expiry
12.2.1.2 Timelines from Drug Development to Commercial Launch
12.2.1.3 New Drug Application
12.2.1.3.1 Documentation and Approval Process
12.3 Cost of Treatment
12.4 Investment Scenarios
12.5 Regulatory Framework
12.5.1 Regulatory Overview
12.5.1.1 US FDA
12.5.1.2 EU EMA
12.5.1.3 INDIA CDSCO
12.5.1.4 JAPAN PMDA
12.5.1.5 Others
13 Challenges and Unmet Need
13.1 Treatment Pathway Challenges
13.2 Compliance and Drop-Out Rate
13.3 Awareness and Prevention Gaps
14 Global Exosomes Drug Market Dynamics
14.1 Market Drivers and Constraints
14.2 SWOT Analysis
14.3 Drug Adoption Parameters
14.4 Porter's Five Forces Model
14.5 Key Demand Indicators
14.6 Key Price Indicators
14.7 Value Chain Analysis
15 Supplier Landscape
15.1 Danaher Corporation (Beckman Coulter Inc.)
15.1.1 Company Overview
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 Hologic Inc.
15.2.1 Company Overview
15.2.2 Product portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Lonza Group AG
15.3.1 Company Overview
15.3.2 Product portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Fujifilm Holdings Corporation
15.4.1 Company Overview
15.4.2 Product portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Miltenyi Biotec GmbH
15.5.1 Company Overview
15.5.2 Product portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Qiagen N.V.
15.6.1 Company Overview
15.6.2 Product portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Thermo Fisher Scientific Inc.
15.7.1 Company Overview
15.7.2 Product portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 JSR Corporation (MBL International)
15.8.1 Company Overview
15.8.2 Product portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Illumina, Inc.
15.9.1 Company Overview
15.9.2 Product portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Takara Bio Inc.
15.10.1 Company Overview
15.10.2 Product portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
15.11 Malvern Instruments Ltd. (Spectris Plc Company)
15.11.1 Company Overview
15.11.2 Product portfolio
15.11.3 Demographic Reach and Achievements
15.11.4 Mergers and Acquisitions
15.11.5 Certifications
15.12 Abcam Plc.
15.12.1 Company Overview
15.12.2 Product portfolio
15.12.3 Demographic Reach and Achievements
15.12.4 Mergers and Acquisitions
15.12.5 Certifications
15.13 Ampersand Capital Partner (New England Peptide, Inc.)
15.13.1 Company Overview
15.13.2 Product portfolio
15.13.3 Demographic Reach and Achievements
15.13.4 Mergers and Acquisitions
15.13.5 Certifications
15.14 Evox Therapeutics Ltd.
15.14.1 Company Overview
15.14.2 Product portfolio
15.14.3 Demographic Reach and Achievements
15.14.4 Mergers and Acquisitions
15.14.5 Certifications
16 Pricing Models and Strategies (Additional Insight)
16.1 Cost Model
16.1.1 Manufacturing Cost Analysis
16.1.2 Procurement Cost Analysis
16.2 Pricing Strategies
16.2.1 Competitor Pricing Analysis
16.2.2 Key Assessment of Product Attributes
16.2.3 Pricing Benchmark
17 Global Exosomes Drug Market- Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security